RedHill’s Opaganib Selected by the NIH Radiation and Nuclear Countermeasures Program
- Tuesday, February 28, 2023, 7:12
- PR Newswire
- Add a comment
The National Institutes of Health’s (NIH) Radiation and Nuclear Countermeasures Program (RNCP) has selected opaganib for testing via their radiation medical countermeasures Product Development Support contract as a potential treatment for Acute Radiation Syndrome (ARS) The RNCP is tasked…
About the Author
admin has written 20022 stories on this site.